Provided are a fetal movement detection device and a fetal movement detection system for home use. The fetal movement detection device includes a sheet body, a plurality of sensors, and a controller. The sheet body which is bendable and extends planarly is comprised of a first sheet layer and a second sheet layer which are fixed to each other, and a back surface of the sheet body contacts an abdomen of a maternal body of a pregnant person. Each sensor has a sensor body to detect a fetal movement of the fetus inside a uterus of the maternal body, and an output line connected to an output end of the sensor body. In each sensor, the entire sensor body and an output end of the output line are both covered by the sheet body. The fetal movement detection system includes the device and a cloud server.

An electrode sheet is flexibly adapted to the position where a signal is acquired. The electrode sheet is attached to a living body and acquires a biological signal, and is provided with a sheet-form biological signal acquisition unit, which is attached to a living body part where a biological signal is acquired. A reference potential acquisition unit extends from the living body signal acquisition unit and is attached to a living body part where a reference potential is acquired. The reference potential acquisition unit is provided with multiple electrodes, which are arranged at a prescribed interval along the direction of extension. Each of the electrodes can attach to the living body part where the reference potential is acquired.

A patient monitoring system includes: a biomedical sensor including: a transducer configured to produce a signal corresponding to a biological function; a sensor converter configured to convert the signal to a converted signal; and a transmitter configured to produce a communication, based on the converted signal, that is indicative of one or more values of the biological function, and to send the communication wirelessly; and a base station including: a receiver configured to receive the communication wirelessly and to produce a receiver output signal; a base station interface configured to produce a base station output signal indicative of the one or more values of the biological function; and at least one output port to receive the base station output signal and configured to be hard-wire connected to a display that is configured to display information indicative of the biological function.

Fetal tissue oxygenation may be performed transabdominally by, for example, receiving a plurality of detected electronic signals that correspond to light emitted from a pregnant mammal's abdomen and a fetus contained therein that has been detected by the detector and converted into the detected electronic signal. An indication of a depth of the fetus within the pregnant mammal's abdomen may be received and a portion of the detected electronic signals that correspond to light that was incident upon the fetus may be isolated responsively to the indication of the depth of the fetus using, for example, time of flight of photons that correspond to the detected electronic signals. A fetal tissue oxygen saturation level may then be determined using the isolated portion of the detected electronic signals that correspond to light that was incident upon the fetus.

Described herein is an apparatus to detect fetal acidosis during labor. This apparatus, which is noninvasive to the fetus, has a pH sensor and at least one fetal tissue detector. When the apparatus is inserted into the vaginal canal of a patient during labor, the pH reading determined by the pH sensor correlates to the pH of the fetus's blood. The fetal tissue detector may be a pulse oximeter, which may allow for a user to obtain the pulse rate reading of a surface contacted by the pH sensor. This pulse rate reading may be compared to an external reading of a pulse rate of the patient to confirm whether the pH sensor is contacting the fetus. During travel through the vaginal canal, the pH sensor may be protected by a protective sheath with an area of weakness to allow exposure of the pH sensor when the fetus is reached.

A method and a system for measuring various physical parameters of a subject by a user using a wearable diagnostic device which comprises of an apparel with a modular sensor matrix disposed in it. The modular sensor matrix is configured to enable a user to measure physical parameters of the subject. The apparel also has display visual display unit disposed on it, which is configured to exhibit measured physical parameters of the subject.

An assembly and method for positioning a fetal heart transducer against skin. The assembly includes a strip having first and second ends and openings along its length, first and second fixation devices, each device having first and second surfaces, the first surface having adhesive thereon. A protuberance extends outwardly from the second surface. The assembly includes a fetal heart transducer. The first fixation device is secured to the skin at a first location and the protuberance of the first fixation device is received into a first opening on the first end of the strip. The first surface of the second fixation device is secured to the skin at a second location and the protuberance of the second fixation device is received into a second opening on the second end of the strip. The fetal heart transducer is secured between first and second fixation devices and beneath the strip.

A decision support tool is provided for predicting the neonatal vitality scores of a fetus during delivery, the scores being an indicator of future health for the infant anticipated to be born within a future time interval, measured as time to birth. The predicted neonatal vitality score is determined from measurements of physiological variables monitored during labor, such as uterine activity and fetal heart rate. Fetal heart rate variability and patterns may be detected and computed using the monitored physiological variables, and neonatal vitality scores may be predicted based, at least in part, on the variability metrics and fetal heart rate patterns. Scores may be predicted for different delivery methods, such as vaginal delivery or cesarean delivery, for different time-to-birth intervals. In this way, these scores may be used for decision support for care plans during labor, such as increased monitoring and/or modifying the delivery type.

Systems and methods are provided for enhanced heart medical imaging operations, particularly as by incorporating use of artificial intelligence (AI) based fetal heart functional analysis and/or real-time and automatic ejection fraction (EF) measurement and analysis.

Systems and methods are described, and one method includes determining a fetal blood oxygenation level, including: activating at least one light source with at least two distinct wavelengths of light on an abdomen of a pregnant mammal to direct light into a maternal abdomen toward a fetus; receiving a set of mixed signals from a set of photodetectors positioned at different locations on the maternal abdomen from reflected light that traverses maternal tissue or maternal tissue and fetal tissue; determining the fetal blood oxygenation level by performing computations on a composite fetal signal produced from the mixed signals; and ensuring a skin temperature of the maternal abdomen does not rise to unsafe levels due to activating the at least one light source.